our team

Patrick joined Aquilo Capital in 2014. From 2005-2014 he worked as a research scientist in various drug development capacities for several public and private biotech firms, including Sutro Biopharma, Exelixis and Xoma. This experience includes research and development for preclinical and clinical stage products in oncology and inflammatory diseases. Patrick received his B.S. in Chemical Engineering at UCLA and his MBA from UC Berkeley’s Haas School of Business.